Summit Global Investments - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 3 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$320
+47.5%
33,225
+62.5%
0.02%
+50.0%
Q2 2023$217
+55.0%
20,440
+53.7%
0.01%
+27.3%
Q1 2023$140
-15.2%
13,3000.0%0.01%
-21.4%
Q4 2022$165
-99.9%
13,300
+2.3%
0.01%
+16.7%
Q3 2022$135,000
-72.3%
13,000
-68.9%
0.01%
-61.3%
Q4 2021$487,000
-51.9%
41,742
-46.2%
0.03%
-59.2%
Q3 2021$1,013,000
+16.2%
77,542
+14.5%
0.08%
+46.2%
Q2 2021$872,000
+9.8%
67,742
-4.6%
0.05%
+2.0%
Q1 2021$794,00071,0420.05%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders